Automating clinical trial data validation when the world needed it most

Prior to the onset of Covid-19, Pfizer understood the need to automate and enhance the statistical analysis QC process.
This is why they collaborated with Beaconcure on a system to ensure the accuracy of clinical deliverables accuracy.

When the pandemic hit, Pfizer was able to leverage this system – called Verify – when the world needed it most.

Verify uses machine learning and natural language processing to validate statistical analysis outputs regardless of the format or structure. Pfizer has implemented Verify for all studies, including COVID-19 studies, safely reducing the time to the availability of study results and, ultimately, the time to submission.

The Results:

• 
  De-risking the Submission
  De-risking and enhancing the quality of its submission by identifying discrepancies earlier in the process.
• 
  First to Market
  Introducing the vaccine to market faster, which made various levels of immunity to COVID-19 accessible around the world.
• 
  Early Release
  Earlier release means earlier sales under the set IP timelines.